4dx share price forecast

March 5, James Mickleboro. The latest member of the All Ordinaries index is getting some love this week.

The 4Dmedical Ltd stock price is 0. The 4DX stock price can go up from 0. The 4DX "4DX" future stock price will be 1. According to our analysis, this will not happen. Not within a year.

4dx share price forecast

About the company. Stable Share Price: 4DX's share price has been volatile over the past 3 months. It commercializes XV Technology, a four-dimensional lung imaging technology. The company also offers software as a service delivery model; XV lungs ventilation analysis software; Permetium, a preclinical imaging system which quantify regional changes in pulmonary function; and AccuVent , a small animal ventilator. Trading at Revenue is forecast to grow Analysts in good agreement that stock price will rise by Currently unprofitable and not forecast to become profitable over the next 3 years. Shareholders have been diluted in the past year. New minor risk - Profitability Feb No longer forecast to breakeven Feb Dec See more updates Recent updates.

Sign up or Log in to use Premium functions. New minor risk - Market cap size Sep A nationally recognised leader in genitourinary 4dx share price forecast thoracic oncology in the United States, Robert's research focuses on renal cell carcinoma and thoracic malignancies.

EPS is expected to grow by Return on equity is forecast to be Earnings growth rate. Earnings vs Savings Rate: 4DX is forecast to remain unprofitable over the next 3 years. Earnings vs Market: 4DX is forecast to remain unprofitable over the next 3 years. High Growth Earnings: 4DX is forecast to remain unprofitable over the next 3 years.

March 5, James Mickleboro. The latest member of the All Ordinaries index is getting some love this week. January 22, James Mickleboro. December 22, James Mickleboro. Analysts have put buy ratings on these small caps and see big potential returns. December 5, James Mickleboro. December 1, James Mickleboro. November 29, James Mickleboro. November 20, James Mickleboro.

4dx share price forecast

Key events shows relevant news articles on days with large price movements. Imugene Ltd. IMU 0.

Toppr jobs

Change: 0. Sales Growth. High number of new directors Jun It commercializes XV Technology, a four-dimensional lung imaging technology. First half earnings released Aug March 5, James Mickleboro. New minor risk - Profitability Sep Price Sensitive Only? Sep Currently, Julian is responsible for the sales and marketing function of Brown Advisory in Australia. Show recent events. It is the first FDA-cleared respiratory imaging solution that uses mathematical models and algorithms to convert sequences of X-ray images into four-dimensional quantitative data. Normalised EPS.

EPS is expected to grow by Return on equity is forecast to be Earnings growth rate.

New minor risk - Profitability Feb Through its flagship patented XV Technology, the Company enables physicians to understand regional airflow in the lungs and identify respiratory deficiencies earlier and with greater sensitivity as they breathe. Today's Open. Cashflow ps. Stock Turnover. Earnings vs Market: 4DX is forecast to remain unprofitable over the next 3 years. John has considerable commercial experience with multiple listed companies. Bullish or Bearish? We can't guarantee any profit. The 4DX "4DX" future stock price will be 1.